Misspelling of cinnamon.

Misspelling of cinnamons.

An experimental drug for the treatment of acute decompensated heart failure.

A 5-HT2A and 5-HT2C receptor antagonist, effective against SARS.

(pharmacology) A drug C₂₂H₂₂F₃N·HCl (trademark Sensipar) that is administered orally to treat hyperparathyroidism in patients with chronic kidney failure undergoing dialysis and to treat certain types of hypercalcemia (as that associated with parathyroid carcinoma). It increases the sensitivity of receptor cells of the parathyroid gland to extracellular calcium causing a decrease in parathyroid hormone secretion.

A beta-adrenergic blocking drug.

(pharmacology) The compound (E)-4-[[3-(2-(4-cyclobutyl-2-thiazolyl)ethenyl)phenyl]amino]-2,2-diethyl-4-oxobutanoic acid that is used in the treatment of asthma